TherapeuticsMD, Inc. (TXMD) reporting calendar
TherapeuticsMD, Inc. files periodic reports with the SEC as TXMD on Nasdaq. Atlas tracks 73 filed reports for this issuer, each linked to its original EDGAR accession.
- Next window
- 20 Jul 2026 – 4 Sep 2026
- Latest report
- 10-Q
- Period ended
- 31 Mar 2026
- Filed
- 12 May 2026
- Reports on record
- 73
How this window is derived. Derived from this issuer's own filing history: 9 periods at a median 91-day cadence, filed a median 43 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.
Open TXMD market profile
Latest filing on SEC EDGAR ↗
Pharmaceutical Preparations reporting datesAll Nasdaq reporting dates
Filed periodic reports
| Form | Period ended | Filed | Lag | SEC accession |
|---|---|---|---|---|
| 10-Q | 31 Mar 2026 | 12 May 2026 | 42 days | 0001213900-26-055081 |
| 10-K | 31 Dec 2025 | 30 Mar 2026 | 89 days | 0001213900-26-036515 |
| 10-Q | 30 Sep 2025 | 12 Nov 2025 | 43 days | 0001213900-25-109381 |
| 10-Q | 30 Jun 2025 | 12 Aug 2025 | 43 days | 0001213900-25-075003 |
| 10-Q | 31 Mar 2025 | 13 May 2025 | 43 days | 0001213900-25-042697 |
| 10-K | 31 Dec 2024 | 27 Mar 2025 | 86 days | 0001013762-25-003442 |
| 10-Q | 30 Sep 2024 | 12 Nov 2024 | 43 days | 0001213900-24-096811 |
| 10-Q | 30 Jun 2024 | 12 Aug 2024 | 43 days | 0001213900-24-067771 |
| 10-Q | 31 Mar 2024 | 10 May 2024 | 40 days | 0001213900-24-041738 |
| 10-K | 31 Dec 2023 | 29 Mar 2024 | 89 days | 0001213900-24-028003 |
| 10-Q | 30 Sep 2023 | 14 Nov 2023 | 45 days | 0001193125-23-277143 |
| 10-Q | 30 Jun 2023 | 14 Aug 2023 | 45 days | 0001193125-23-211458 |
| 10-Q | 31 Mar 2023 | 15 May 2023 | 45 days | 0001193125-23-145064 |
| 10-K | 31 Dec 2022 | 7 Apr 2023 | 97 days | 0001564590-23-005514 |
| 10-Q | 30 Sep 2022 | 14 Nov 2022 | 45 days | 0001564590-22-037666 |
| 10-Q | 30 Jun 2022 | 15 Aug 2022 | 46 days | 0001564590-22-029490 |
| 10-Q | 31 Mar 2022 | 16 May 2022 | 46 days | 0001564590-22-020440 |
| 10-K | 31 Dec 2021 | 23 Mar 2022 | 82 days | 0001564590-22-011525 |
| 10-Q | 30 Sep 2021 | 12 Nov 2021 | 43 days | 0001564590-21-056434 |
| 10-Q | 30 Jun 2021 | 4 Aug 2021 | 35 days | 0001564590-21-040907 |
| 10-Q | 31 Mar 2021 | 6 May 2021 | 36 days | 0001193125-21-153419 |
| 10-K | 31 Dec 2020 | 4 Mar 2021 | 63 days | 0001387131-21-003140 |
| 10-Q | 30 Sep 2020 | 9 Nov 2020 | 40 days | 0001387131-20-009695 |
| 10-Q | 30 Jun 2020 | 7 Aug 2020 | 38 days | 0001387131-20-007144 |
| 10-Q | 31 Mar 2020 | 6 May 2020 | 36 days | 0001387131-20-004479 |
| 10-K | 31 Dec 2019 | 24 Feb 2020 | 55 days | 0001387131-20-002086 |
| 10-Q | 30 Sep 2019 | 8 Nov 2019 | 39 days | 0001387131-19-008469 |
| 10-Q | 30 Jun 2019 | 9 Aug 2019 | 40 days | 0001387131-19-005935 |
| 10-Q | 31 Mar 2019 | 8 May 2019 | 38 days | 0001387131-19-003457 |
| 10-K | 31 Dec 2018 | 27 Feb 2019 | 58 days | 0001387131-19-001471 |
| 10-Q | 30 Sep 2018 | 8 Nov 2018 | 39 days | 0001387131-18-005976 |
| 10-Q | 30 Jun 2018 | 30 Jul 2018 | 30 days | 0001387131-18-003401 |
| 10-Q | 31 Mar 2018 | 7 May 2018 | 37 days | 0001387131-18-001945 |
| 10-K | 31 Dec 2017 | 23 Feb 2018 | 54 days | 0001387131-18-000776 |
| 10-Q | 30 Sep 2017 | 7 Nov 2017 | 38 days | 0001387131-17-005313 |
| 10-Q | 30 Jun 2017 | 3 Aug 2017 | 34 days | 0001387131-17-003894 |
| 10-Q | 31 Mar 2017 | 3 May 2017 | 33 days | 0001387131-17-002419 |
| 10-K | 31 Dec 2016 | 28 Feb 2017 | 59 days | 0001387131-17-001111 |
| 10-Q | 30 Sep 2016 | 4 Nov 2016 | 35 days | 0001387131-16-007716 |
| 10-Q | 30 Jun 2016 | 5 Aug 2016 | 36 days | 0001387131-16-006337 |
Source: SEC EDGAR company submissions for CIK 0000025743. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.